LGR4 and neoplasm: In the future, by constructing mouse models carrying humanized LGR4 mutations and discovering new endogenous LGR4 ligands, the unique signaling pathway of LGR4 can be further elucidated, which will lay the foundation for the application of LGR4 in the treatment of bone metabolic diseases and tumor bone metastasis.